No abstract available
Publication types
-
Editorial
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Angiotensin-Converting Enzyme 2
-
Antiviral Agents / pharmacology*
-
Betacoronavirus* / drug effects
-
Betacoronavirus* / pathogenicity
-
Betacoronavirus* / physiology
-
COVID-19
-
Coronavirus Infections* / drug therapy
-
Coronavirus Infections* / metabolism
-
Coronavirus Infections* / physiopathology
-
Coronavirus Infections* / prevention & control
-
Drug Development / methods
-
Drug Development / trends
-
Enzyme Inhibitors / pharmacology
-
Heart* / drug effects
-
Heart* / physiopathology
-
Heart* / virology
-
Humans
-
Myocarditis* / metabolism
-
Myocarditis* / physiopathology
-
Myocarditis* / prevention & control
-
Myocarditis* / virology
-
Myocytes, Cardiac* / physiology
-
Myocytes, Cardiac* / virology
-
Pandemics* / prevention & control
-
Peptidyl-Dipeptidase A / metabolism
-
Pneumonia, Viral* / drug therapy
-
Pneumonia, Viral* / metabolism
-
Pneumonia, Viral* / physiopathology
-
Pneumonia, Viral* / prevention & control
-
SARS-CoV-2
-
Virus Internalization / drug effects
Substances
-
Antiviral Agents
-
Enzyme Inhibitors
-
Peptidyl-Dipeptidase A
-
ACE2 protein, human
-
Angiotensin-Converting Enzyme 2